Abstract: The invention discloses an inserting rod type quick connection device, which comprises an upper sleeve and a lower sleeve with an opening at one end, wherein the upper sleeve is provided with an inserting rod extending out of the opening, the open end of the lower sleeve is provided with a detachable extrusion sleeve, the extrusion sleeve is provided with a plurality of extrusion gaskets, wherein the plurality of extrusion gaskets are fitted and connected to form a hollow conical cylinder structure, the outer conical surface of the conical cylinder is provided with a spiral groove, and a conical spring is sleeved in the spiral groove, the outer diameter and the inner diameter of the conical cylinder gradually decrease from the lower end surface to the upper end surface, wherein the inserting rod is conical, and the taper of the inserting rod is the same as that of the inner conical surface of the conical cylinder.

Abstract: A compound serving as a BTK inhibitor, a preparation method therefor, and a use thereof. The compound has a structure represented by formula I, or a tautomer, a mesomer, a racemate, an enantiomer, a diastereomer or a mixture thereof, or a pharmaceutically acceptable hydrate, solvent, or salt thereof, wherein A1, A2, A3, A4, A5 and A6 are each independently selected from C—R5 and N, and at least one of those is N; and M is selected from substituted or unsubstituted saturated or heterosaturated hydrocarbyl, substituted or unsubstituted unsaturated cyclic group or heterocyclyl, and substituted or unsubstituted monocyclic, bicyclic, or tricyclic aryl or heteroaryl. The provided BTK protein kinase inhibitor has strong inhibition for wild BTK and mutated BTK (C481S), has good pharmacokinetic properties, and has good application prospects.

Abstract: There are provided compounds of Formula I, and pharmaceutically acceptable salts and esters thereof, and pharmaceutical compositions thereof, used for inhibition or modulation of the activity of cyclin dependent kinases (CDK) and/or glycogen synthase kinase-3 (GSK-3), for the treatment of disease states or conditions mediated by cyclin dependent kinases and/or glycogen synthase kinase-3, including cancers.

Abstract: A back contact solar cell string includes: at least two cell pieces, where each cell piece comprises positive electrode regions and negative electrode regions alternately disposed with each other; insulation layers, covering the positive electrode regions on one side of the cell piece and the negative electrode regions on another side of the cell piece; and a first bus bar, connected to two adjacent cell pieces and electrically connected to the positive electrode regions and the negative electrode regions in the two adjacent cell pieces that are not covered by the insulation layers.

Abstract: A method for soldering a solar cell, includes: placing a plurality of back contact cells on a soldering platform, where back surfaces of the back contact cells face away from the soldering platform, and electrodes corresponding to two adjacent back contact cells have opposite polarities in a connection direction of a plurality of to-be-connected ribbons; placing the plurality of to-be-connected ribbons on the electrodes of the plurality of back contact cells by using a first clamping portion, a second clamping portion, and a plurality of third clamping portions, where the first clamping portion, the second clamping portion, and the plurality of third clamping portions respectively correspond to head ends, tail ends, and middle portions of the plurality of ribbons; and heating the plurality of ribbons by using a heater to connect the plurality of ribbons to the plurality of back contact cells.

Abstract: Described is a system including a display, a display controller, and control logic communicatively coupled to the display. The display controller determines, based on coordinates of a focus point on the display, boundaries of a first image region and a second image region in an output image to be rendered. The focus point is determined through tracking an eye movement of a user viewing the display. The first image region has a higher resolution than the second image region. The display controller is configured to send image data together with control signals to the control logic. The control signals cause the control logic to render the output image on the display using the image data. As part of rendering the second image region, the control logic outputs a shared signal onto signal lines that are coupled to light sources in a group of adjacent rows or columns.

Abstract: A system and method for plasma enhanced deposition processes. An exemplary semiconductor manufacturing system includes a susceptor configured to hold a semiconductor wafer and a sector disposed above the susceptor. The sector includes a first plate and an overlying second plate, operable to form a plasma there between. The first plate includes a plurality of holes extending through the first plate, which vary in at least one of diameter and density from a first region of the first plate to a second region of the first plate.

Abstract: The present disclosure provides for a method of making a plant growth medium comprising isolating cellulose nanocrystals from a feedstock, and adding the cellulose nanocrystals to the plant growth medium. Further provided herein is a plant starter plug comprising the plant growth medium. Also provided herein is a plant growth medium comprising germination material and cellulose nanocrystals, and a plant starter plug comprising thereof. The present disclosure further provides for a method of isolating CNCs from waste.

Abstract: Bridged compounds of Formula (I) and Formula (II), pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions associated with MGL modulation, such as those associated with pain, psychiatric disorders, neurological disorders (including, but not limited to major depressive disorder, treatment resistant depression, anxious depression, bipolar disorder), cancers and eye conditions. wherein R2, R3 R4, R5 and R6 are defined herein.

Abstract: A pressing device is provided, including: a main body, including a chamber; a pushing assembly, including a retractable mechanism movably inserted within the chamber, a first pushing board connected with the retractable mechanism and a restricting member embedded within the chamber and blocking the retractable mechanism from moving out of the chamber; a hydraulic mechanism, including a tube body which is connected with the main body and communicated with the chamber, a driving rod movably inserted within the tube body and a piston driven by the driving rod, the piston being configured to drive fluid to flow in or out of the chamber. Another pressing device is further provided, differing from the pressing device described above in that: the main body further including a channel, a wall of the chamber including at least one recession which is communicated with the channel.

Abstract: Disclosed herein are adiponectin receptor agonists and methods of using the same for the treatment of inflammation or bone loss in a subject.

Abstract: In order to provide an environmentally secured voltage testing interface, an electrical enclosure box comprising a front panel is herein-described, into which is mounted a voltage indicator comprising a plurality of LED indicators that indicate a status of one or more circuits coupled thereto and monitored thereby. A test point device is also mounted through the front panel and comprises an interface comprising a plurality of external measurement sockets configured to receive one or more probes for manual measurement of voltages, wherein each external measurement socket is coupled to a voltage divider that is further coupled to each of a plurality of respective wires coupled to respective LED indicators of the voltage indicator.

Abstract: Provided herein are radiopharmaceutical compositions and uses thereof. The radiopharmaceutical compositions can comprise one or more stabilizing agents, an aqueous vehicle, and a conjugate that comprises a targeting ligand and a radionuclide bound to a metal chelator. The targeting ligand can be a small molecule compound or a peptide such as a monocyclic peptide. The targeting ligand can be configured to bind with a tumor target. The stabilizing agent can comprise a radiolysis stabilizer, a free metal chelator, and/or a pH stabilizer. Further provided herein are methods of preparing the radiopharmaceutical compositions and methods of treating cancer by administering the described radiopharmaceutical compositions.

Abstract: Embodiments of the present invention is an inertial measurement module, including a mount, a circuit board, a thermally conductive member and a cover plate mounted to the mount. The circuit board is mounted to an end surface of the mount, and is configured to mount an inertial measurement assembly and the thermally conductive member. The inertial measurement assembly includes a thermal resistor and an inertial measurement unit. The thermally conductive member is configured to abut against the thermal resistor and the inertial measurement unit. A surface of the cover plate is provided with a first groove. A receiving space is formed by the first groove and the surface of the mount. The circuit board and the thermally conductive member are both received in the receiving space. The thermally conductive member is arranged at a preset distance from a bottom of the first groove.

Abstract: Techniques for high-performance machine learning (ML) inference in heterogenous edge devices are described. A ML model trained using a variety of different frameworks is translated into a common format that is runnable by inferences engines of edge devices. The translated model is optimized in hardware-agnostic and/or hardware-specific ways to improve inference performance, and the optimized model is sent to the edge devices. The inference engine for any edge device can be accessed by a customer application using a same defined API, regardless of the hardware characteristics of the edge device or the original format of the ML model.

Abstract: A plug-in network device is disclosed. The plug-in network device can be used in association with a network management system and an infrastructure network device. The plug-in network device includes two antenna arrays, one of which is up-facing and one of which is front-facing. The plug-in network device can achieve wireless communication with the infrastructure network device via the up-facing antenna array and provide network services to wireless stations through the front-facing antenna array. The network management system can manage both the infrastructure network device and the plug-in network device.

Abstract: Transistors include trenches formed in the semiconductor substrate having a first conductive type. The trenches define, in a channel width plane of the transistor, at least one nonplanar substrate structure having a plurality of sidewall portions and a tip portion disposed between the plurality of sidewall portions. An epitaxial overlayer is epitaxially grown on the sidewall portions and the tip portion. A channel doping layer having a doped portion of the semiconductor substrate is formed in the nonplanar substrate structure and enclosed by the epitaxial overlayer. An isolation layer is disposed in the trenches and over the epitaxial overlayer. A gate is disposed on the isolation layer and extends into the trenches.

Abstract: Disclosed herein are heterocyclic compounds that may be used as STING modulators, the process for synthesis and to the use of such compounds in treatment of various diseases including cancers.

Abstract: A back contact structure of a solar cell, includes: a silicon substrate, the silicon substrate including a back surface including a plurality of recesses disposed at intervals; a plurality of first conductive regions and a plurality of second conductive regions disposed alternately in the plurality of recesses, where each first conductive region includes a first dielectric layer and a first doped region which are disposed successively in the plurality of recesses, and each second conductive region includes a second doped region; a second dielectric layer disposed between the plurality of first conductive regions and the plurality of second conductive regions; and a conductive layer disposed on the plurality of first conductive regions and the plurality of second conductive regions.

Abstract: A method for forming a pixel includes forming, in a semiconductor substrate, a wide trench having an upper depth with respect to a planar top surface of the semiconductor substrate. The method also includes ion-implanting a floating-diffusion region between the planar top surface and a junction depth in the semiconductor substrate. In a cross-sectional plane perpendicular to the planar top surface, the floating-diffusion region has (i) an upper width between the planar top surface and the upper depth, and (ii) between the upper depth and the junction depth, a lower width that exceeds the upper width. Part of the floating-diffusion region is beneath the wide trench and between the upper depth and the junction depth.